Goldenwell Biotech Inc (GWLL)
0.20
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Goldenwell Biotech Cash from Financing (Quarterly): 0.0619M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.0619M |
September 30, 2023 | 0.03M |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.03M |
December 31, 2022 | 0.905M |
September 30, 2022 |
Date | Value |
---|---|
June 30, 2022 | 0.00 |
March 31, 2022 | |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.1701M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2021
0.905M
Maximum
Dec 2022
0.1197M
Average
0.015M
Median
Cash from Financing (Quarterly) Benchmarks
Coty Inc | 21.80M |
Bemax Inc | 0.2188M |
e.l.f. Beauty Inc | 203.87M |
Ingles Markets Inc | -11.19M |
Village Super Market Inc | -6.616M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.0206M |
Free Cash Flow | -0.1147M |
Free Cash Flow Per Share (Quarterly) | -0.0002 |
Free Cash Flow to Equity (Quarterly) | -0.0206M |
Free Cash Flow Yield | -0.59% |